Sfoglia per Autore
Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: results of a prospective, randomized trial
2013-01-01 Oliva, En; Santini, V; Zini, G; Palumbo, G; Poloni, Antonella; Cortelezzi, A; Rodeghiero, F; Voso, Mt; Molteni, A; Sanpaolo, G; Liberati, M; Morabito, F; Balleari, E; Impera, S; Salvi, F; Aloe Spiriti, Ma; Marini, A; Rodà, F; Alati, C; Ronco, F; Di Raimondo, F; Leoni, Pietro; Alimena, G; Latagliata, R; Nobile, F.
Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients
2013-01-01 Santini, V; Allione, B; Lunghi, M; Levis, A; Poloni, Antonella; Angelucci, E; Onida, F; Terenzi, A; Finelli, C; Ferrero, D.
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.
2013-01-01 Rippo, Maria Rita; Babini, L; Prattichizzo, Francesco; Graciotti, Laura; Fulgenzi, Gianluca; Tomassoni Ardori, F; Olivieri, Fabiola; Borghetti, G; Cinti, Saverio; Poloni, Antonella; Fazioli, Francesca; Procopio, Antonio Domenico
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study
2013-01-01 Messa, Emanuela; Gioia, Daniela Maria; Masiera, Elisa; Allione, Bernardino; Angelucci, Emanuele; Balleari, Enrico; Bonferroni, Margherita; Cametti, Gianni; Centurioni, Riccardo; Crisà, Elena; Cilloni, Daniela; Danise, Paolo; Corso, Lisette Del; Ferrero, Dario; Finelli, Carlo; Freilone, Roberto; Gaidano, Gianluca; Lunghi, Monia; Musto, Pellegrino; Oliva, Esther Natalie; Pappano, Stefano; Pelizzari, Anna Maria; Poloni, Antonella; Santini, Valeria; Salvi, Flavia; Tassara, Rodolfo; Visani, Giuseppe; Saglio, Giuseppe; Lev, Alessandro
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
2013-01-01 Olivieri, Attilio; M., Cimminiello; P., Corradini; N., Mordini; R., Fedele; C., Selleri; F., Onida; F., Patriarca; E., Pavone; SVEGLIATI BARONI, Silvia; Gabrielli, Armando; P., Bresciani; R., Nuccorini; S., Pascale; S., Coluzzi; F., Pane; Poloni, Antonella; Olivieri, Jacopo; Leoni, Pietro; A., Bacigalupo
The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism
2013-01-01 Santini, Valeria; Schemenau, Jennifer; Levis, Alessandro; Balleari, Enrico; Sapena, Rosa; Ades, Lionel; Guerci, Agnès; Beyne Rauzy, Odile; Gourin, Marie Pierre; Cheze, Stéphane; Stamatoullas, Aspasia; Sanna, Alessandro; Gioia, Daniela; Cametti, Giani; Ferrero, Dario; Raffoux, Emmanuel; Rose, Christian; Poloni, Antonella; Prebet, Thomas; Ame, Shanti; Legros, Laurence; Fenaux, Pierre; Germing, Ulrich; Dreyfus, Francois; Park, Sophie
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chonic myelomonocytic leukemia
2013-01-01 Voso, Mt; Breccia, M; Lunghi, M; Poloni, Antonella; Niscola, P; Finelli, C; Bari, A; Musto, P; Zambello, R; Fianchi, L; Alimena, G; Leone, G.
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome
2013-01-01 Poloni, Antonella; Federica, Serrani; Eleonora, Berardinelli; Giulia, Maurizi; Marianna, Mariani; Benedetta, Costantini; Silvia, Trappolini; Stefania, Mancini; Olivieri, Attilio; Leoni, Pietro
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
2013-01-01 Poloni, Antonella; Goteri, Gaia; Zizzi, A; Serrani, Federica; Trappolini, Silvia; Costantini, Benedetta; Mariani, M; Olivieri, Attilio; Catarini, M; Centurioni, R; Alesiani, F; Giantomassi, F; Stramazzotti, Daniela; Biagetti, S; Alfonsi, S; Berardinelli, E; Leoni, Pietro
Lenalidomide in International Prognostic Scoring System low and intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
2013-01-01 Oliva, En; Latagliata, R; Laganà, C; Breccia, M; Galimberti, S; Morabito, F; Poloni, Antonella; Balleari, E; Cortelezzi, A; Palumbo, G; Sampaolo, G; Volpe, A; Specchia, G; Finelli, C; D'Errigo, Mg; Rodà, F; Alati, C; Alimena, G; Nobile, F; Aloe Spiriti, Ma
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME
2014-01-01 Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella
‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS
2014-01-01 Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A.
HUMAN MATURE BONE MARROW ADIPOCYTES MANTAIN THE SURVIVAL AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS
2014-01-01 Maurizi, G; 1 Mattiucci, D; 1 Mancini, S; Olivieri, Attilio; Cinti, Saverio; 2 Leoni, P; Poloni, Antonella
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE
2014-01-01 Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio
MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA
2014-01-01 Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients.
2014-01-01 Scortechini, Ilaria; Montanari, M; Mancini, Giorgia; Inglese, E; Calandrelli, M; Chiarucci, M; Offidani, M; Capelli, D; Gini, G; Poloni, Antonella; Mancini, Stefania; Raggetti, G; Leoni, Pietro; Olivieri, Attilio
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes
2014-01-01 Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; S., Amatori; B., Fogliardi; Costantini, Benedetta; Mariani, Marianna; Mancini, Stefania; Olivieri, Attilio; M., Fanelli; Leoni, Pietro
MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA
2014-01-01 Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1
Molecular Determinants of Decitabine Response in Chronic Myelomonocytic Leukemia
2014-01-01 Rossi, Alessia; Meldi, Kristen; Martinez, Ana Belen Valencia; Abdel Wahab, Omar; Micol, Jean Baptiste; Tingting, Qin; Buchi, Francesca; Masala, Erico; Sanna, Alessandro; Allione, Bernardino; Lunghi, Monia; Onida, Francesco; Poloni, Antonella; Angelucci, Emanuele; Finelli, Carlo; Levis, Alessandro; Gioia, Daniela; Figueroa, Maria E; Santini, Valeria
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin
2014-01-01 Capelli, D; Chiarucci, Martina; Poloni, Antonella; Saraceni, Francesco; Mancini, Giorgia; Trappolini, Silvia; Troiani, E; Montanari, M; Scortechini, Ilaria; Offidani, M; Rupoli, S; Scortechini, Anna Rita; Gini, G; Discepoli, G; Leoni, Pietro; Olivieri, Attilio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: results of a prospective, randomized trial | 1-gen-2013 | Oliva, En; Santini, V; Zini, G; Palumbo, G; Poloni, Antonella; Cortelezzi, A; Rodeghiero, F; Voso, Mt; Molteni, A; Sanpaolo, G; Liberati, M; Morabito, F; Balleari, E; Impera, S; Salvi, F; Aloe Spiriti, Ma; Marini, A; Rodà, F; Alati, C; Ronco, F; Di Raimondo, F; Leoni, Pietro; Alimena, G; Latagliata, R; Nobile, F. | |
Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients | 1-gen-2013 | Santini, V; Allione, B; Lunghi, M; Levis, A; Poloni, Antonella; Angelucci, E; Onida, F; Terenzi, A; Finelli, C; Ferrero, D. | |
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. | 1-gen-2013 | Rippo, Maria Rita; Babini, L; Prattichizzo, Francesco; Graciotti, Laura; Fulgenzi, Gianluca; Tomassoni Ardori, F; Olivieri, Fabiola; Borghetti, G; Cinti, Saverio; Poloni, Antonella; Fazioli, Francesca; Procopio, Antonio Domenico | |
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study | 1-gen-2013 | Messa, Emanuela; Gioia, Daniela Maria; Masiera, Elisa; Allione, Bernardino; Angelucci, Emanuele; Balleari, Enrico; Bonferroni, Margherita; Cametti, Gianni; Centurioni, Riccardo; Crisà, Elena; Cilloni, Daniela; Danise, Paolo; Corso, Lisette Del; Ferrero, Dario; Finelli, Carlo; Freilone, Roberto; Gaidano, Gianluca; Lunghi, Monia; Musto, Pellegrino; Oliva, Esther Natalie; Pappano, Stefano; Pelizzari, Anna Maria; Poloni, Antonella; Santini, Valeria; Salvi, Flavia; Tassara, Rodolfo; Visani, Giuseppe; Saglio, Giuseppe; Lev, Alessandro | |
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD | 1-gen-2013 | Olivieri, Attilio; M., Cimminiello; P., Corradini; N., Mordini; R., Fedele; C., Selleri; F., Onida; F., Patriarca; E., Pavone; SVEGLIATI BARONI, Silvia; Gabrielli, Armando; P., Bresciani; R., Nuccorini; S., Pascale; S., Coluzzi; F., Pane; Poloni, Antonella; Olivieri, Jacopo; Leoni, Pietro; A., Bacigalupo | |
The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism | 1-gen-2013 | Santini, Valeria; Schemenau, Jennifer; Levis, Alessandro; Balleari, Enrico; Sapena, Rosa; Ades, Lionel; Guerci, Agnès; Beyne Rauzy, Odile; Gourin, Marie Pierre; Cheze, Stéphane; Stamatoullas, Aspasia; Sanna, Alessandro; Gioia, Daniela; Cametti, Giani; Ferrero, Dario; Raffoux, Emmanuel; Rose, Christian; Poloni, Antonella; Prebet, Thomas; Ame, Shanti; Legros, Laurence; Fenaux, Pierre; Germing, Ulrich; Dreyfus, Francois; Park, Sophie | |
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chonic myelomonocytic leukemia | 1-gen-2013 | Voso, Mt; Breccia, M; Lunghi, M; Poloni, Antonella; Niscola, P; Finelli, C; Bari, A; Musto, P; Zambello, R; Fianchi, L; Alimena, G; Leone, G. | |
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome | 1-gen-2013 | Poloni, Antonella; Federica, Serrani; Eleonora, Berardinelli; Giulia, Maurizi; Marianna, Mariani; Benedetta, Costantini; Silvia, Trappolini; Stefania, Mancini; Olivieri, Attilio; Leoni, Pietro | |
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. | 1-gen-2013 | Poloni, Antonella; Goteri, Gaia; Zizzi, A; Serrani, Federica; Trappolini, Silvia; Costantini, Benedetta; Mariani, M; Olivieri, Attilio; Catarini, M; Centurioni, R; Alesiani, F; Giantomassi, F; Stramazzotti, Daniela; Biagetti, S; Alfonsi, S; Berardinelli, E; Leoni, Pietro | |
Lenalidomide in International Prognostic Scoring System low and intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy | 1-gen-2013 | Oliva, En; Latagliata, R; Laganà, C; Breccia, M; Galimberti, S; Morabito, F; Poloni, Antonella; Balleari, E; Cortelezzi, A; Palumbo, G; Sampaolo, G; Volpe, A; Specchia, G; Finelli, C; D'Errigo, Mg; Rodà, F; Alati, C; Alimena, G; Nobile, F; Aloe Spiriti, Ma | |
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME | 1-gen-2014 | Mattiucci, Domenico; Maurizi, G; Amatori, S; Costantini, B; Mariani, M; Mancini, Stefania; Fanelli, M; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella | |
‘MEMORIAL’ PLUS AMIFOSTINE EFFICACY AND FEASIBILITY IN AN ELDERLY COHORT OF 149 AML PATIENTS | 1-gen-2014 | Capelli, D; Chiarucci, M; Saraceni, F; Poloni, Antonella; Mancini, G; Trappolini, S; Offidani, M; Rupoli, S; Montanari, M; Scortechini, Ar; Gini, G; Scortechini, I; Discepoli, G; Leoni, P; Olivieri, A. | |
HUMAN MATURE BONE MARROW ADIPOCYTES MANTAIN THE SURVIVAL AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS | 1-gen-2014 | Maurizi, G; 1 Mattiucci, D; 1 Mancini, S; Olivieri, Attilio; Cinti, Saverio; 2 Leoni, P; Poloni, Antonella | |
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE | 1-gen-2014 | Capelli, D; Attolico, I; Saraceni, Francesco; Mancini, Stefania; Scortechini, Ar; Poloni, Antonella; Bartocci, C; Viola, N; Pascale, S; Nuccorini, R; Chiarucci, Martina; Serrani, F; Pizzuti, M; Leoni, Pietro; Olivieri, Attilio | |
MECHANISM OF RESISTANCE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA | 1-gen-2014 | Rossi A, Valencia A; Meldi K, Buchi F; Poloni, Antonella | |
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. | 1-gen-2014 | Scortechini, Ilaria; Montanari, M; Mancini, Giorgia; Inglese, E; Calandrelli, M; Chiarucci, M; Offidani, M; Capelli, D; Gini, G; Poloni, Antonella; Mancini, Stefania; Raggetti, G; Leoni, Pietro; Olivieri, Attilio | |
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes | 1-gen-2014 | Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; S., Amatori; B., Fogliardi; Costantini, Benedetta; Mariani, Marianna; Mancini, Stefania; Olivieri, Attilio; M., Fanelli; Leoni, Pietro | |
MOLECULAR PREDICTORS OF RESPONSE TO DECITABINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA | 1-gen-2014 | Rossi, A; 1 Valencia, A; 1 Abdel Wahab, O; 2 Figueroa, Me; 3 Tingting, Q; 3 Meldi, K; 3 Buchi, F; 1 Masala, E; 1 Sanna, A; 1 Allione, B; 4 Lunghi, M; Poloni, Antonella; 6 Angelucci, E; 7 Finelli, C; 8 Levis, A; 9 Santini, V1 | |
Molecular Determinants of Decitabine Response in Chronic Myelomonocytic Leukemia | 1-gen-2014 | Rossi, Alessia; Meldi, Kristen; Martinez, Ana Belen Valencia; Abdel Wahab, Omar; Micol, Jean Baptiste; Tingting, Qin; Buchi, Francesca; Masala, Erico; Sanna, Alessandro; Allione, Bernardino; Lunghi, Monia; Onida, Francesco; Poloni, Antonella; Angelucci, Emanuele; Finelli, Carlo; Levis, Alessandro; Gioia, Daniela; Figueroa, Maria E; Santini, Valeria | |
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin | 1-gen-2014 | Capelli, D; Chiarucci, Martina; Poloni, Antonella; Saraceni, Francesco; Mancini, Giorgia; Trappolini, Silvia; Troiani, E; Montanari, M; Scortechini, Ilaria; Offidani, M; Rupoli, S; Scortechini, Anna Rita; Gini, G; Discepoli, G; Leoni, Pietro; Olivieri, Attilio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile